Medicilon held the Preclincial and IND Declaration Seminar in Chengdu, China. Medicilon CEO Chun-Lin Chen gave a speech during the seminar where he shared his experience on IND filling for both US and China. Professor Shuangqing Peng had a topic on New Drug Safety Evaluation Approach. Dr. Baomin Xin, Medicilon VP of DMPK and BA,Read more
Dear Clients, Collaborative Partners and Friends, As the end of year is approaching, we would like to express our sincere gratitude for your business. Thank you so much for all your trust and support! During the season, the team at Medicilon wishes you peace, joy and prosperity throughout the coming year. Warmest Holiday Greetings toRead more
Every animal model of disease comes with its own unique set of drawbacks. Yet, scientists continually push to improve the quality of animal models to recapitulate the physiological and molecular signatures of disease states. For decades, researchers have turned to mice whose immune systems have been “humanized” to respond in a manner similar to humans.Read more
Scientists at the Van Andel Research Institute have developed a novel biochemical platform to research a family of enzymes that are promising targets for cancer treatment. The study (“A functional proteomics platform to reveal the sequence determinants of lysine methyltransferase substrate selectivity”), published in Science Advances, describes a new method that provides a high-resolution view ofRead more
Shanghai Medicilon Inc.